Simulations Plus, Inc. (SLP)
NASDAQ: SLP · Real-Time Price · USD
16.68
+0.62 (3.86%)
At close: May 8, 2026, 4:00 PM EDT
16.34
-0.34 (-2.04%)
After-hours: May 8, 2026, 7:58 PM EDT
Simulations Plus Employees
As of August 31, 2025, Simulations Plus had 213 total employees, including 212 full-time and 1 part-time employees. The number of employees decreased by 34 or -13.77% compared to the previous year.
Employees
213
Change (1Y)
-34
Growth (1Y)
-13.77%
Revenue / Employee
$378,099
Profits / Employee
-$294,775
Market Cap
337.03M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Aug 31, 2025 | 213 | -34 | -13.77% | 212 | 1 |
| Aug 31, 2024 | 247 | 50 | 25.38% | 243 | 4 |
| Aug 31, 2023 | 197 | 34 | 20.86% | 192 | 5 |
| Aug 31, 2022 | 163 | 17 | 11.64% | 157 | 6 |
| Aug 31, 2021 | 146 | 9 | 6.57% | 135 | 11 |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evolent Health | 4,200 |
| TruBridge | 3,500 |
| Claritev | 3,000 |
| So-Young International | 2,348 |
| Phreesia | 1,789 |
| Weave Communications | 904 |
| SOPHiA GENETICS | 415 |
| Spok Holdings | 415 |
SLP News
- 3 days ago - Simulations Plus, Nvidia collaborate to scale AI-assisted modeling workflows - TheFly
- 4 days ago - Simulations Plus and NVIDIA Collaborate to Scale GPU-Accelerated, AI-Assisted Modeling Workflows - Business Wire
- 19 days ago - Simulations Plus enters funded research collaboration with Lonza, FDA - TheFly
- 19 days ago - Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products - Business Wire
- 20 days ago - Simulations Plus announces completion of 2026 Spring School - TheFly
- 20 days ago - Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School - Business Wire
- 4 weeks ago - Simulations Plus price target lowered to $16 from $19 at TD Cowen - TheFly
- 4 weeks ago - Simulations Plus Earnings Call Transcript: Q2 2026 - Transcripts